Hims & Hers Health (HIMS) Stock Forecast & Price Target

HIMS price $29.55 +0.23 +0.80%

Ticker
HIMS
Price
$29.55
Change
+0.23 +0.80%
Market cap ?
$6.65B
P/E ?
-48.07
Forward P/E ?
99.07
Dividend yield ?
0.00%
Beta ?
2.43
Sector
Healthcare
Industry
Medical - Care Facilities
Stocklytics score
47
Value
55
Quality
20
Growth
65

Stocklytics score rationale: value 55, quality 20, growth 65.

Financials

2019202020212022202320242025
8255800014875700027187800052691600087200000014765140002347637000

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide…

Forecast

Consensus Hold from 16 analysts. Average price target $32.17, +8.8% versus the current price. Low $24.50. High $42.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Analysts have an average 12-month price target of $32.17 for Hims & Hers Health (HIMS), 8.0% above the current price of $29.80. Of 16 analysts covering the stock, 3 rate it Buy or Strong Buy, 12 Hold, and 1 Sell or Strong Sell, giving a consensus of Hold.

Forecasts are third-party estimates and often wrong. They are not investment advice.

HIMS price target

12-month price target
Low$24.50
Average$32.17
High$42.00

The average is 8.0% above the current price of $29.80.

Is Hims & Hers Health a buy or sell?

Of 16 analysts, 3 rate Hims & Hers Health Buy or Strong Buy, 12 Hold, and 1 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.

Hims & Hers Health earnings and revenue forecast

Analyst averages on file: 2026, EPS -0.59, revenue $3.21 billion. 2027, EPS $0.30, revenue $4.05 billion.

HIMS score and fair value

The Stocklytics Score for HIMS is 47 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.

HIMS forecast FAQs

What is the HIMS price target?

$32.17 average, with a published range of $24.50 to $42.00.

Is Hims & Hers Health a buy or sell?

The consensus is Hold from 16 analysts. This is not a recommendation.

What is the Hims & Hers Health stock forecast for 2026?

Analysts' average EPS estimate for 2026 on file is -0.59. The average revenue estimate is $3.21 billion.

What will HIMS be worth in 2030?

No reliable forecast exists that far out.

When is Hims & Hers Health's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Related: Hims & Hers Health · Financials · Dividends · Compare · AI stocks

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

Hims & Hers Health (HIMS) Stock Forecast & Price Target

HIMS$29.55+0.23 +0.80%

$6.65B

Market Cap

-48.07

P/E

99.07

Forward P/E

47

Score

Price History